James Morgan
Psychiatric/Mental Health · Kings Park, NYNPI 1578018107
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 24.8% of the total. 2025 is the largest year on record at $1,630, 2.3 times the $712 reported in 2021. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $25.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Axsome Therapeutics, Inc.$586
- Otsuka America Pharmaceutical, Inc.$467
- Alkermes, Inc.$420
- AbbVie$382
- plus $872 from 7 others
What the payments were for
- Food & beverage$5,32399%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 42 | $1,332 |
| Takeda Pharmaceuticals U.S.A., Inc. | 60 | $1,312 |
| Axsome Therapeutics, Inc. | 19 | $586 |
| Otsuka America Pharmaceutical, Inc. | 15 | $467 |
| Alkermes, Inc. | 11 | $420 |
| AbbVie | 16 | $382 |
| Lundbeck LLC | 16 | $330 |
| Idorsia Pharmaceuticals US Inc | 17 | $288 |
| Bausch Health US, LLC | 6 | $96 |
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| Corium, LLC | 2 | $36 |
| Johnson & Johnson | 1 | $28 |
| Almatica Pharma LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,370 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 25 | $9,733 |
| Zolpidem Tartrate | 51 | $3,067 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 14 | $250 |
| Alprazolam | 53 | $232 |
| Clonazepam | 25 | $151 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Kings Park
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Elijah StevensBinghamton$131K
- Kayanna JonasFar Rockaway$93K
- Alexis CrisafiFishkill$70K
- Vera ImperialeAlbany$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.